Updated 04:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,051.60 -0.56% CL 102.78 +2.88% BTC 79,693.74 -1.38%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,052 −0.56% BTC $79,694 −1.38% VIX 16.91 −3.48% latest tape · as of 04:01 UTC
The Screen · Utilities · Utilities - Regulated Gas

Spire Inc.

SR · the NYSE · USD · Market cap $4.9B · 3,497 employees

Spire Inc., together with its subsidiaries, engages in the purchase, retail distribution, and sale of natural gas to residential, commercial, industrial, and other end-users of natural gas in the United States.

FAIL · Does not pass the screen
85.24 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago

Screened 2026-10-23 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price85.24 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.00)
  • Last reviewed23 Oct 2026 (6 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
69.6869.6880.13

What this means: price 85.24 against the desk's fair-value range, base estimate 69.68, over the last year.

Current read
Accumulation ?
Screened · screened 2026-10-23
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.00, read 2026-10-24
  • Ethical does not pass the values gate
Price85.24 USD
Fair value69.68
Ethical score70.0/100
Our investment reviews on this name
2026-10-25Read Accumulation82.89+2.8% to today ✓Markdown gives way to Accumulation
2026-09-13Read Markdown80.20+6.3% to today Accumulation gives way to Markdown with volume flow in agreement
2026-08-13Read Accumulation80.84+5.4% to today ✓Distribution gives way to Accumulation
2026-07-02Read Distribution79.10+7.8% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Spire Inc. holds its Accumulation at $85.24. The statistical read favours the buyers, held for 424 days.

As held on the ledger · 2026-10-23
PhaseAccumulation
Quantitative stateThe statistical read favours the buyers, held for 424 days
Price at the screen$85.24
Valuation24.03 trailing · 15.11 forward price to earnings
Values screenFAIL · score 70.0
Beta0.54
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 44.70% Below 33% Interest-bearing debt is 44.7% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 1.71% Below 49% Money owed to the company is 1.7% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Spire's business is in a permissible area, but its interest-bearing debt is about 45% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when SR's ethical verdict changes

Today SR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

69.68Conservative69.68Base case80.13Growth case 85.24Price

Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 18.3% above the base estimate.

The Street's Range
79.00Street low 93.00Street average 102.00Street high 85.24Price

Third-party analyst targets: 10 covering, consensus Buy. The average target sits +9% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections
$106$78$51TODAY5y agoPROJECTIONStreet high$102.00 +27%Street avg$93.00 +16%Conservative$69.68 -13%Our fair value$69.68 -13%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Gas bills arrive but value stays elusive

Picture a utility that simply pipes natural gas to homes and factories month after month. Spire does exactly that, yet the shares sit 13 percent above our fair value with no margin of safety at the current price. Revenue edges up only 4 percent a year, the return on equity is a modest 9 percent, and the forward multiple of 14.7 times earnings offers little cushion once the cycle turns.

We pass because the business sits in a cyclical industry where low multiples often signal peak earnings rather than a bargain. The ethical screen is cleared, yet that alone does not create an opportunity when growth is thin and returns remain ordinary. Analyst targets sit higher, but those views ignore how regulated returns compress when interest rates or input costs shift.

The real risk is that investors treat steady cash flows as permanent while earnings prove more elastic than the multiple implies. A regulated franchise can still disappoint when volumes or allowed rates move against it. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E15.1xfairly priced for its growth rate
Trailing P/E24.0xa premium valuation
EPS, trailing3.45
EPS, forward5.49
Revenue growth+19.2%steady growth
Profit margin20.6%healthy profit margins
Return on equity8.1%a modest return on shareholder capital
FCF yield-6.53%
Dividend yield417.00%
Debt to equity2.03heavy leverage: higher risk if revenue softens
Current ratio0.37below 1: short-term bills exceed liquid assets
Beta0.54steadier than the market
Short interest, float0.07%
52-week range74.84 - 95.31
Market cap$4.9B
Employees3,497

The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

SR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Accumulation · changed $82.89 +3.9% Entry 8

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-10-18 Markdown $79.80 +4.4% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-10-02 Markdown $76.44 -4.7% Entry 6

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-09-13 Markdown · changed $80.20 -0.8% Entry 5

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-08-13 Accumulation · changed $80.84 +2.2% Entry 4

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-07-18 Distribution $79.10 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (9 analysts) rates it buy, with a mean price target of $99.

2026-07-03 Distribution $79.10 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Distribution $79.10 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on SR

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in SR's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming SR
DatePoliticianPartyTypeAmount
2026-05-15 Ro Khanna Democrat buy 15K–50K
2026-05-14 Josh Gottheimer Democrat sell 1K–15K
2026-05-05 Josh Gottheimer Democrat sell 1K–15K
2026-05-01 Ro Khanna Democrat buy 1K–15K
2026-05-01 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $85.76 -6.4% · $936 -6.4%
2 months $94.38 -15.0% · $851 -15.0%
3 months $91.22 -12.0% · $880 -12.0%
6 months $81.39 -1.4% $0.83 $996 -0.4%
1 year $71.62 +12.1% $3.22 $1,166 +16.6%
2 years $54.97 +46.0% $6.30 $1,575 +57.5%
3 years $58.48 +37.3% $8.53 $1,518 +51.8%
5 years $61.74 +30.0% $14.08 $1,528 +52.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever SR does next, these words stay.

Spire Inc. · SR · Accumulation · $85.24
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.